Related Experiment Video
Updated: Apr 9, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Gut Microbiota: Association with NAFLD and Metabolic Disturbances
E Lau1, D Carvalho1, P Freitas1
1Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar São João, Institute for Research and Innovation in Health Sciences, Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal.
Abstract:
Nonalcoholic fatty liver disease is the hepatic expression of metabolic syndrome, being frequently associated with obesity, insulin resistance, and dyslipidemia. Recent lines of evidence have demonstrated a role of gut microbiota in insulin resistance, obesity, and associated metabolic disturbances, raising the interest in its relationship with NAFLD pathogenesis. Therefore, intestinal microbiota has emerged as a potential factor involved in NAFLD, through different pathways, including its influence in energy storage, lipid and choline metabolism, ethanol production, immune balance, and inflammation. The main objective of this review is to address the pathogenic association of gut microbiota to NAFLD. This comprehension may allow the development of integrated strategies to modulate intestinal microbiota in order to treat NAFLD.
Related Concept Videos
Functions of the Gut Microbiota
Gut-Brain Axis
Microbiota of the Large Intestine
Development of Human Microbiota
The Oral Microbiota
Microbiota of the Stomach and Small Intestine

